Pulmonary disposition of vancomycin in critically ill patients

被引:0
|
作者
H. Georges
O. Leroy
S. Alfandari
B. Guery
M. Roussel-Delvallez
C. Dhennain
G. Beaucaire
机构
[1] Hôpital Chatilliez,Service Universitaire de Réanimation Médicale et Maladies Infectieuses
[2] Lille University Medical School,Laboratoire de Bacteriologie, Hôpital A. Calmette
[3] Hôpital Chatilliez,Laboratoire de Bacteriologie
关键词
Internal Medicine; Pneumonia; Plasma Concentration; Plasma Level; Minimum Inhibitory Concentration;
D O I
暂无
中图分类号
学科分类号
摘要
Vancomycin penetration in epithelium lining fluid was studied in ten mechanically ventilated patients with methicillin-resistantStaphylococcus aureus pneumonia 24 hours after the onset of treatment. Vancomycin was given intravenously at a daily dose of 30 mg/kg. Vancomycin levels were detectable in four patients (range, 1–2.77 μg/ml). Concordance between high plasma concentrations (> 20 μg/ml) and detectable vancomycin levels in epithelium lining fluid was noted. These results suggest that the pulmonary disposition of vancomycin remains low for most patients 24 h after the onset of treatment compared with the minimum inhibitory concentrations for most gram-positive organisms. One therapeutic goal of vancomycin treatment could be to obtain through plasma levels of 20 μg/ml. Further studies are required to determine the clinical relevance of these observations.
引用
收藏
页码:385 / 388
页数:3
相关论文
共 50 条
  • [31] New Regimen for Continuous Infusion of Vancomycin in Critically Ill Patients
    Cristallini, Stefano
    Hites, Maya
    Kabtouri, Hakim
    Roberts, Jason A.
    Beumier, Marjorie
    Cotton, Frederic
    Lipman, Jeffrey
    Jacobs, Frederique
    Vincent, Jean-Louis
    Creteur, Jacques
    Taccone, Fabio Silvio
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (08) : 4750 - 4756
  • [32] External Validation of Obese/Critically Ill Vancomycin Population Pharmacokinetic Models in Critically Ill Patients Who Are Obese
    Alsultan, Abdullah
    Dasuqi, Shereen A.
    Almohaizeie, Abdullah
    Aljutayli, Abdullah
    Aljamaan, Fadi
    Omran, Rasha A.
    Alolayan, Abdulaziz
    Hamad, Mohammed A.
    Alotaibi, Haifa
    Altamimi, Sarah
    Alghanem, Sarah S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (03): : 353 - 361
  • [33] DYNAMIC PULMONARY HYPERINSUFFLATION IN CRITICALLY ILL PATIENTS
    BLANCH, L
    FERNANDEZ, R
    ROMERO, PV
    MEDICINA CLINICA, 1992, 99 (16): : 627 - 635
  • [34] PULMONARY EXTRACTION OF CATECHOLAMINES IN CRITICALLY ILL PATIENTS
    RUSSELL, WJ
    FREWIN, DB
    JONSSON, JR
    ANAESTHESIA AND INTENSIVE CARE, 1982, 10 (04) : 319 - 323
  • [35] Adiponectin in Pulmonary Disease and Critically Ill Patients
    Garcia, P.
    Sood, A.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (32) : 5493 - 5500
  • [36] Pulmonary and Physical Rehabilitation in Critically Ill Patients
    Jang, Myung Hun
    Shin, Myung-Jun
    Shin, Yong Beom
    ACUTE AND CRITICAL CARE, 2019, 34 (01) : 1 - 13
  • [37] Pharmacokinetics of vancomycin in critically ill patients undergoing continuous venovenous haemodialysis
    Chaijamorn, Weerachai
    Wanakamanee, Usanee
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (04) : 367 - 368
  • [38] IMPACT OF AUGMENTED RENAL CLEARANCE ON VANCOMYCIN IN CRITICALLY ILL TRAUMA PATIENTS
    Rice, Timothy
    Droege, Molly
    Philpott, Carolyn
    Courter, Joshua
    Desai, Pankaj
    Harger, Nicole
    Ernst, Neil
    Foertsch, Madeline
    Healy, Daniel
    Karve, Aniruddha
    Liao, Siyun
    Mueller, Eric
    Winter, Jessica
    Goodman, Michael
    Droege, Chris
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 642 - 642
  • [39] Necessity of a loading dose when using vancomycin in critically ill patients
    Wang, JT
    Fang, CT
    Chen, YC
    Chang, SC
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (02) : 246 - 246
  • [40] Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients
    Chaijamorn, Weerachai
    Jitsurong, Arnurai
    Wiwattanawongsa, Kamonthip
    Wanakamanee, Usanee
    Dandecha, Phongsak
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 (02) : 152 - 156